| 淡江大學 |
2003-12-18 |
PEG/PLLA摻合體氧化裂解之研究
|
吳容銘 |
| 亞東技術學院 |
2010-05-27 |
PEGAE 型陽離子界面活性劑合成及對纖維素纖維染色性之研究
|
李承書 |
| 國立臺灣科技大學 |
2013 |
PEGAS: Partitioned GTS allocation scheme for IEEE 802.15.4 networks
|
Al Rasyid, M.U.H.;Lee, B.-H.;Sudarsono, A. |
| 朝陽科技大學 |
2009-04-24 |
PEGASIS架構之長存活期無線感測網路之鏈結頭選擇
|
戴良峻;黃永發;林仁勇; Yung-Fa Huang |
| 臺大學術典藏 |
2021-09-04T05:16:56Z |
Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: A systematic review and meta-analysis of individual participant data
|
Pavlovic V.; Yang L.; Chan H.L.-Y.; Hou J.; Janssen H.L.; JIA-HORNG KAO; Lampertico P.; Peng C.-Y.; Piratvisuth T.; Thompson A.J.; Wedemeyer H.; Wei L.; Wat C. |
| 國立臺灣大學 |
2004 |
Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with Hbeag-Negative Chronic Hepatitis B
|
賴明陽; PATRICK MARCELLIN; LAU, GEORGE K .K.; FERRUCCIO BONINO; PATRIZIA FARCI; STEPHANOS HADZIYANNIS; JIN RUI; LU, ZHI-MENG; TEERHA PIRATVISUTH; GEORGIOS GERMANIDIS; CIHAN YURDAYDIN; MOISES DIAGO; SELIM GURE; LAI, MING-YANG |
| 國立臺灣大學 |
2007 |
Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in Hcv
|
劉振驊; 陳定信; 高嘉宏; LIU, CHEN-HUA; CHEN, DING-SHINN; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T06:40:18Z |
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV [6]
|
Liu, C.-H. and Chen, D.-S. and Kao, J.-H.; CHEN-HUA LIU |
| 臺大學術典藏 |
2021-05-24T07:20:56Z |
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV [6]
|
CHEN-HUA LIU; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:12:38Z |
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV [6]
|
Liu C.-H.; Chen D.-S.; JIA-HORNG KAO |
| 國立臺灣大學 |
2007-11 |
Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in HCV.
|
Liu, CH; Chen, DS; Kao, JH. |
| 臺大學術典藏 |
2018-09-10T06:14:05Z |
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV.
|
CHEN-HUA LIU; CHEN-HUA LIU |
| 國立臺灣大學 |
2000 |
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
|
賴明陽; LAI, MING-YANG |
| 國立成功大學 |
2014-06-17 |
Peginterferon Alfa-2a Is Associated with Elevations in Alanine Aminotransferase at the End of Treatment in Chronic Hepatitis C Patients with Sustained Virologic Response
|
Tseng, Chih-Wei; Chen, Chi-Yi; Chang, Ting-Tsung; Tzeng, Shinn-Jia; Hsieh, Yu-Hsi; Hung, Tsung-Hsing; Lee, Ching-Chih; Wu, Shu-Fen; Tseng, Kuo-Chih |
| 國立臺灣大學 |
2012 |
Peginterferon alfa-2a plus Low Dose Ribavirin versus Peginterferon alfa-2a Monotherapy for Dialysis Patients with Hepatitis C Virus Genotype 1 Infection: A Randomized Trial
|
Liu, Chen-Hua; Liang, Cheng-Chao; Su, Tung-Hung; Hung, Peir-Haur; Tsai, Hung-Bin; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2009 |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses
|
劉俊人; 莊萬龍; 李全謨; 余明隆; 盧勝男; 吳順生; 陳祈玲; 楊賢馨; 高嘉宏; 劉振驊; 蘇維文; 鄭永銘; 陳培哲; 陳定信; LIU, CHUN-JEN; CHUANG, WAN-LONG; LEE, CHUAN-MO; YU, MING-LUNG; LU, SHENG-NAN; WU, SHUN-SHENG; CHEN, CHI-LING; YANG, SIEN-SING; KAO, JIA-HORNG; LIU, CHEN-HUA; SU, WEI-WEN; JENG, YUNG-MING; CHEN, PEI-JER; CHEN, DING-SHINN |
| 臺大學術典藏 |
2018-09-10T07:37:25Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu, Chun-Jen;Chuang, Wan-Long;Lee, Chuan-Mo;Yu, Ming-Lung;Lu, Sheng-Nan;Wu, Shun-Sheng;Chen, Chi-Ling;Yang, Sien-Sing;Kao, Jia-Horng;Liu, Chen-Hua;Su, Wei-Wen;Jeng, Yung-Ming;Chen, Pei-Jer;Chen, Ding-Shinn; CHUN-JEN LIU; YUNG-MING JENG; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO; LIU, CHUN-JEN; CHUANG, WAN-LONG; LEE, CHUAN-MO; YU, MING-LUNG; LU, SHENG-NAN; WU, SHUN-SHENG; CHEN, CHI-LING; YANG, SIEN-SING; KAO, JIA-HORNG; LIU, CHEN-HUA; SU, WEI-WEN; JENG, YUNG-MING; CHEN, PEI-JER; CHEN, DING-SHINN |
| 臺大學術典藏 |
2020-03-06T08:25:25Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu C.; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; Kao J.; Liu C.; Su W.; Lin C.; YUNG-MING JENG; Chen P.; Chen D. |
| 臺大學術典藏 |
2021-05-24T07:20:53Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
CHEN-HUA LIU; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; Kao J.; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D. |
| 臺大學術典藏 |
2021-07-03T03:34:53Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu C.; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; Kao J.; Liu C.; Su W.; Lin C.; Jeng Y.; PEI-JER CHEN; Chen D. |
| 臺大學術典藏 |
2022-01-24T09:32:02Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
CHUN-JEN LIU; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; Kao J.; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D. |
| 臺大學術典藏 |
2022-01-25T05:10:37Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu C.; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; CHI-LING CHEN; Kuo H.; Chao Y.; Tung S.; Yang S.; Kao J.; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D. |
| 臺大學術典藏 |
2021-09-04T06:12:27Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu C.; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; JIA-HORNG KAO; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D. |
| 國立臺灣大學 |
2008-11 |
Peginterferon alfa-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial
|
Liu, CH; Liu, CJ; Lin, CL; Liang, CC; Hsu, SJ; Yang, SS; Hsu, CS; Tseng, TC; Wang, CC; Lai, MY; Chen, JH; Chen, PJ; Chen, DS; Kao, JH |
| 臺大學術典藏 |
2021-07-12T02:44:40Z |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Na?ve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu C.-H; | Huang C.-F; | Liu C.-J; | Dai C.-Y; | Huang J.-F; | Lin J.-W; | Liang C.-C; | Yang S.-S; | Lin C.-L; | Su T.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Chuang W.-L; | Kao J.-H; | Yu M.-L. |
